Ferini, G.; Zagardo, V.; Critelli, P.; Santacaterina, A.; Sava, S.; Harikar, M.M.; Venkataram, T.; Umana, G.E.; Viola, A.; Valenti, V.;
et al. Introducing Radiotherapy in Metastatic Merkel Cell Carcinoma Patients with Limited Progression on Avelumab: An Effective Step against Primary and Secondary Immune Resistance? J. Pers. Med. 2023, 13, 841.
https://doi.org/10.3390/jpm13050841
AMA Style
Ferini G, Zagardo V, Critelli P, Santacaterina A, Sava S, Harikar MM, Venkataram T, Umana GE, Viola A, Valenti V,
et al. Introducing Radiotherapy in Metastatic Merkel Cell Carcinoma Patients with Limited Progression on Avelumab: An Effective Step against Primary and Secondary Immune Resistance? Journal of Personalized Medicine. 2023; 13(5):841.
https://doi.org/10.3390/jpm13050841
Chicago/Turabian Style
Ferini, Gianluca, Valentina Zagardo, Paola Critelli, Anna Santacaterina, Serena Sava, Mandara Muralidhar Harikar, Tejas Venkataram, Giuseppe Emmanuele Umana, Anna Viola, Vito Valenti,
and et al. 2023. "Introducing Radiotherapy in Metastatic Merkel Cell Carcinoma Patients with Limited Progression on Avelumab: An Effective Step against Primary and Secondary Immune Resistance?" Journal of Personalized Medicine 13, no. 5: 841.
https://doi.org/10.3390/jpm13050841
APA Style
Ferini, G., Zagardo, V., Critelli, P., Santacaterina, A., Sava, S., Harikar, M. M., Venkataram, T., Umana, G. E., Viola, A., Valenti, V., & Forte, S.
(2023). Introducing Radiotherapy in Metastatic Merkel Cell Carcinoma Patients with Limited Progression on Avelumab: An Effective Step against Primary and Secondary Immune Resistance? Journal of Personalized Medicine, 13(5), 841.
https://doi.org/10.3390/jpm13050841